Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,100 public trials 1,856 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Completed

A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT00556712

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • St Leonards, New South Wales, Australia
  • Waratah, New South Wales, Australia
  • Brisbane, Queensland, Australia
  • Adelaide, South Australia, Australia
View all 133 locations
View Trial Details
Completed

A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer

NCT00653939

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Southbay Oncology Hematology Campbell, California, United States
  • Pacific Coast Hematology and Oncology Medical Group Fountain Valley, California, United States
  • UCLA Division of Hematology and Oncology Los Angeles, California, United States
  • Bay Area Cancer Research Group, LLC Pleasant Hill, California, United States
View all 15 locations
View Trial Details
Completed

S9925: Collecting and Storing Samples From Patients With Lung Cancer

NCT00920010

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Providence Cancer Center at Providence Hospital Mobile, Alabama, United States
  • Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
  • Providence Cancer Center Anchorage, Alaska, United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
View all 431 locations
View Trial Details
Completed

An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.

NCT01386580

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +33 more
Locations
  • UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • Universitair Ziekenhuis Antwerpen Antwerp, Belgium
  • Jules Bordet Institute Brussels, Belgium
  • Institut Curie Paris, Paris Cedex 05, France
View Trial Details

Related conditions